InvestorsHub Logo
Followers 127
Posts 3172
Boards Moderated 0
Alias Born 08/24/2015

Re: maverick_1 post# 574106

Wednesday, 03/08/2023 12:56:17 PM

Wednesday, March 08, 2023 12:56:17 PM

Post# of 705296
Maverick, I think your take is the best one I’ve seen yet and fits well with what I’ve been thinking about and with the crumbs I’ve picked up over the course of the last 10 months. Ms. Hursever makes a lot of sense. I’ve never believed, ever, that LP would sell. Partnerships in some way yes, but not sell. Mike Scott at Advent is a genius and has that place running on high gear and the new UK policy about allowing global shipping of biologics fits right in with bringing in big financial capital, up list, and begin shipping DCVax to where it’s needed on MHRA approvals and then the others fall into place…Canada, FDA, EMA, etc. CRL is poised to decentralize manufacturing and allow price competition with Advent. Having multiple manufacturing sites with Flaskworks adding to the mix is what any Biotech with a translational Cancer treatment would want. I’m sure Merck, BMY, etc. are all kicking themselves for lowballing NWBO in the past only to find out they’ve been had
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News